Standard BioTools to Participate in Upcoming Investor Conferences
22 Februar 2024 - 10:05PM
Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –
Unleashing tools to accelerate breakthroughs in human health™ –
today announced that management will participate in the following
investor conferences:
- TD Cowen’s 44th Annual Healthcare Conference on Wednesday,
March 6, 2024. President and Chief Executive Officer, Michael
Egholm, PhD, will present at 1:30 p.m. ET.
- KeyBanc Capital Markets Life Sciences & MedTech Investor
Forum on Tuesday, March 19, 2024. Egholm will participate in a
fireside chat at 10:30 a.m. ET.
Presentations will be webcast live and available on the Investor
Relations page of the Company’s website at Events &
Presentations. A recording will be archived and available on the
Standard BioTools Investor Relations page at
investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq:LAB), previously known as
Fluidigm Corporation, is driven by a bold purpose – Unleashing
tools to accelerate breakthroughs in human health. Standard
BioTools has an established portfolio of essential, standardized
next-generation technologies that help biomedical researchers
develop medicines faster and better. As a leading solutions
provider, the company provides reliable and repeatable insights in
health and disease using its proprietary mass cytometry and
microfluidics technologies, which help transform scientific
discoveries into better patient outcomes. Standard BioTools works
with leading academic, government, pharmaceutical, biotechnology,
plant and animal research and clinical laboratories worldwide,
focusing on the most pressing needs in translational and clinical
research, including oncology, immunology and immunotherapy. Learn
more at standardbio.com or connect with us on X, Facebook®,
LinkedIn and YouTube™. Standard BioTools, the Standard BioTools
logo, Fluidigm, the Fluidigm logo, “Unleashing tools to accelerate
breakthroughs in human health,” Imaging Mass Cytometry, IMC,
Hyperion, Hyperion XTi and XTi are trademarks and/or registered
trademarks of Standard BioTools Inc. or its affiliates in the
United States and/or other countries. All other trademarks are the
sole property of their respective owners. Standard
BioTools products are provided for Research Use Only. Not for use
in diagnostic procedures.
Available Information
Standard BioTools uses its website (standardbio.com), investor
site (investors.standardbio.com), corporate X account
(@Standard_BioT), Facebook page (facebook.com/StandardBioT), and
LinkedIn page (linkedin.com/company/standard-biotools) as channels
of distribution of information about its products, its planned
financial and other announcements, its attendance at upcoming
investor and industry conferences and other matters. Such
information may be deemed material information, and Standard
BioTools may use these channels to comply with its disclosure
obligations under Regulation FD. Therefore, investors should
monitor Standard BioTools website and its social media accounts in
addition to following its press releases, SEC filings, public
conference calls and webcasts.
Investor Contact:
David Holmesir@standardbio.com
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024